Methylation-based signature to distinguish indolent and aggressive prostate cancer

Authors

Muheng Liao, Washington University School of Medicine in St. Louis
Jace Webster, Washington University School of Medicine in St. Louis
Amy Ly, Washington University School of Medicine in St. Louis
Emily Rozycki, Washington University School of Medicine in St. Louis
Christopher A Maher, Washington University School of Medicine in St. Louis

Journal

Biology Open

Publication Date

12-15-2025

Volume

14

Issue

12

First Page

bio062281

Document Type

Open Access Publication

DOI

10.1242/bio.062281

Rights and Permissions

Liao M, Webster J, Ly A, Rozycki E, Maher CA. Methylation-based signature to distinguish indolent and aggressive prostate cancer. Biol Open. 2025 Dec 15;14(12):bio062281. doi: 10.1242/bio.062281 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

Recommended Citation

Liao, Muheng; Webster, Jace; Ly, Amy; Rozycki, Emily; and Maher, Christopher A, "Methylation-based signature to distinguish indolent and aggressive prostate cancer." Biology Open. 14, 12. bio062281 (2025).
https://digitalcommons.wustl.edu/oa_4/5934

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.